Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
- PMID: 28640269
- DOI: 10.1038/nature22809
Addendum: The antibody aducanumab reduces Aβ plaques in Alzheimer's disease
Abstract
This corrects the article DOI: 10.1038/nature21361.
Erratum for
-
An intermediate-mass black hole in the centre of the globular cluster 47 Tucanae.Nature. 2017 Feb 8;542(7640):203-205. doi: 10.1038/nature21361. Nature. 2017. PMID: 28179649
Update of
-
The antibody aducanumab reduces Aβ plaques in Alzheimer's disease.Nature. 2016 Sep 1;537(7618):50-6. doi: 10.1038/nature19323. Nature. 2016. Update in: Nature. 2017 Jun 21;546(7659):564. doi: 10.1038/nature22809. PMID: 27582220 Updated.
Similar articles
-
Amyloid-Related Imaging Abnormalities (ARIA) in Immunotherapy Trials for Alzheimer's Disease: Need for Prognostic Biomarkers?J Alzheimers Dis. 2016 Mar 29;52(2):417-20. doi: 10.3233/JAD-160122. J Alzheimers Dis. 2016. PMID: 27031492
-
A comparative study of dietary curcumin, nanocurcumin, and other classical amyloid-binding dyes for labeling and imaging of amyloid plaques in brain tissue of 5×-familial Alzheimer's disease mice.Histochem Cell Biol. 2016 Nov;146(5):609-625. doi: 10.1007/s00418-016-1464-1. Epub 2016 Jul 12. Histochem Cell Biol. 2016. PMID: 27406082
-
Safety and biomarker effects of solanezumab in patients with Alzheimer's disease.Alzheimers Dement. 2012 Jul;8(4):261-71. doi: 10.1016/j.jalz.2011.09.224. Epub 2012 Jun 5. Alzheimers Dement. 2012. PMID: 22672770 Clinical Trial.
-
Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease.Neurobiol Aging. 2005 Oct;26(9):1235-44. doi: 10.1016/j.neurobiolaging.2005.05.022. Neurobiol Aging. 2005. PMID: 16023263 Review.
-
Is there still any hope for amyloid-based immunotherapy for Alzheimer's disease?Curr Opin Psychiatry. 2014 Mar;27(2):128-37. doi: 10.1097/YCO.0000000000000041. Curr Opin Psychiatry. 2014. PMID: 24445401 Review.
Cited by
-
CCCDTD5: Reducing the risk of later-life dementia. Evidence informing the Fifth Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD-5).Alzheimers Dement (N Y). 2020 Nov 11;6(1):e12083. doi: 10.1002/trc2.12083. eCollection 2020. Alzheimers Dement (N Y). 2020. PMID: 33204818 Free PMC article.
-
Aβ42 oligomer-specific antibody ALZ-201 reduces the neurotoxicity of Alzheimer's disease brain extracts.Alzheimers Res Ther. 2022 Dec 29;14(1):196. doi: 10.1186/s13195-022-01141-1. Alzheimers Res Ther. 2022. PMID: 36578089 Free PMC article.
-
Transferrin-Conjugated Melittin-Loaded L-Arginine-Coated Iron Oxide Nanoparticles for Mitigating Beta-Amyloid Pathology of the 5XFAD Mouse Brain.Int J Mol Sci. 2023 Oct 6;24(19):14954. doi: 10.3390/ijms241914954. Int J Mol Sci. 2023. PMID: 37834402 Free PMC article.
-
The Lymphatic Vasculature in the 21st Century: Novel Functional Roles in Homeostasis and Disease.Cell. 2020 Jul 23;182(2):270-296. doi: 10.1016/j.cell.2020.06.039. Cell. 2020. PMID: 32707093 Free PMC article. Review.
-
Jatrophane Diterpenoids from Euphorbia peplus Linn. as Activators of Autophagy and Inhibitors of Tau Pathology.Int J Mol Sci. 2023 Jan 6;24(2):1088. doi: 10.3390/ijms24021088. Int J Mol Sci. 2023. PMID: 36674604 Free PMC article.
References
-
- Nature. 2016 Aug 31;537(7618):50-6 - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources